Search for: "Pfizer" Results 121 - 140 of 4,640
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
2 Jun 2023, 3:03 pm by FRANK VINLUAN - MEDCITY NEWS
The post Pfizer’s RSV Vaccine Wins FDA Approval On Heels Of Regulatory Nod For GSK appeared first on Above the Law. [read post]
30 May 2023, 1:01 pm by Tom Smith
Pfizer poured money into news media organizations to promote not just its vaccine but also the crackdown on disfavored speech, like that of Berenson. [read post]
26 May 2023, 7:04 am by FRANK VINLUAN - MEDCITY NEWS
The post FDA Nod Makes Pfizer’s Paxlovid The First Approved Oral COVID-19 Antiviral Drug appeared first on Above the Law. [read post]
25 May 2023, 2:32 am by Kluwer IP Reporter
Patents & Trademarks), and Andrew Rudge (Pfizer) have continued where Derk Visser left off, making sure that Visser’s Annotated European Patent Convention stays up to date. [read post]
23 May 2023, 4:00 am by Leslie Eastman
Meanwhile, Pfizer and Moderna say work on Covid vaccines is not over, even though the public health emergency has ended. [read post]
This is consistent with guidance from the CDC, which continues to recommend that individuals receive the updated Pfizer-BioNTech or Moderna COVID-19 vaccine to reduce the risk of serious illness, hospitalization, and death. [read post]
14 May 2023, 11:28 am by Eric Goldman
With respect to the Twitter Files, “Scott Gottlieb, a board member at Pfizer and a former FDA Commissioner who resigned in 2019—i.e., before the pandemic—wrote to Twitter complaining about one of Hart’s posts…But Dr. [read post]
3 May 2023, 7:00 am by Ronald V. Miller, Jr.
It worked well and Pfizer was printing money from the sales of the drug. [read post]
18 Apr 2023, 8:25 am by Fox Rothschild LLP
  Additional speakers:  Matt Dumiak, Director Privacy Service, Compliance Point Kristin Jones, Managing Senior Counsel, CVS Health Jana Landon, Chief Privacy Officer, Lincoln Financial Group Joanna Levin, Senior Counsel, Global Privacy, Pfizer Lauren Winchester, Senior Vice President of Risk and Response, Corvus Insurance The summit will kick off at 8:30 a.m. [read post]
18 Apr 2023, 8:22 am by Fox Rothschild LLP
  Additional speakers:  Matt Dumiak, Director Privacy Service, Compliance Point Kristin Jones, Managing Senior Counsel, CVS Health Jana Landon, Chief Privacy Officer, Lincoln Financial Group Joanna Levin, Senior Counsel, Global Privacy, Pfizer Lauren Winchester, Senior Vice President of Risk and Response, Corvus Insurance The summit will kick off at 8:30 a.m. [read post]
16 Apr 2023, 9:40 pm by Patent Docs
.; Sharon Reiche of Pfizer Inc.; and Bill Warren of Eversheds Sutherland, who were involved in the preparation of IPO's comments, will cover issues such as trade secret protection, counterfeiting, compulsory licenses, issues in IP enforcement, genetic resources and an overview of developments at multilateral organizations. [read post]
10 Apr 2023, 6:33 am by Kevin Schmidt
  This week, FOIAengine takes a look at some who are bombarding the Food and Drug Administration and other federal agencies with Freedom of Information Act document demands about Pfizer and Moderna. [read post]
7 Apr 2023, 9:15 am by Eileen McDermott
This week in Other Barks & Bites, the United States Court of Appeals for the Federal Circuit (CAFC) rules against Apple in a trademark dispute; Arbutus and Genevant Sciences file a patent infringement lawsuit against Pfizer related to the COVID-19 vaccine; and Sweetgreen promptly changes the name of a menu item after Chipotle files a trademark lawsuit against the salad chain. [read post]
7 Apr 2023, 9:15 am by Eileen McDermott
This week in Other Barks & Bites, the United States Court of Appeals for the Federal Circuit (CAFC) rules against Apple in a trademark dispute; Arbutus and Genevant Sciences file a patent infringement lawsuit against Pfizer related to the COVID-19 vaccine; and Sweetgreen promptly changes the name of a menu item after Chipotle files a trademark lawsuit against the salad chain. [read post]
7 Apr 2023, 7:09 am by alath
Moderna and Pfizer have made more than $100bn (£83; €94) in global revenues from sales of their COVID-19 vaccines. [read post]
5 Apr 2023, 5:18 am by Annsley Merelle Ward
A similar situation arose a few years in Pfizer v Roche [2019] EWHC 1520 (Pat). [read post]
4 Apr 2023, 5:40 pm by Sabrina I. Pacifici
The second shots will be limited to those age 65 and older who got their first shot of the bivalent vaccine made by Moderna or Pfizer-BioNTech at least four months ago, and to those with weakened immune systems who got one of those shots at least two months ago, according to a federal official who was not authorized to speak publicly. [read post]
28 Mar 2023, 9:44 am by James Love
Would Astellas or Pfizer see such a communication from the Biden Administration as an incentive to lower the price, at least to federal programs? [read post]